BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34875583)

  • 1. Precautionary breaks: Planned, limited duration circuit breaks to control the prevalence of SARS-CoV2 and the burden of COVID-19 disease.
    Keeling MJ; Guyver-Fletcher G; Dyson L; Tildesley MJ; Hill EM; Medley GF
    Epidemics; 2021 Dec; 37():100526. PubMed ID: 34875583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth, reproduction numbers and factors affecting the spread of SARS-CoV-2 novel variants of concern in the UK from October 2020 to July 2021: a modelling analysis.
    Ward T; Glaser A; Johnsen A; Xu F; Hall I; Pellis L
    BMJ Open; 2021 Nov; 11(11):e056636. PubMed ID: 34819293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
    Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in Ecuador, a resource-limited setting.
    Moreira-Soto A; Bruno A; de Mora D; Paez M; Garces J; Wulf B; Sander AL; Olmedo M; Basantes Mantilla MJ; Gonzalez Gonzalez M; Orlando SA; Salgado Cisneros S; Zevallos JC; Drexler JF
    Emerg Microbes Infect; 2023 Dec; 12(2):2259001. PubMed ID: 37698611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Non-pharmaceutical Interventions on COVID-19 Mortality: A Generalized Synthetic Control Approach Across 169 Countries.
    Mader S; Rüttenauer T
    Front Public Health; 2022; 10():820642. PubMed ID: 35444988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations and guidance to control the rebound in COVID-19 cases.
    Li Q; Zhan X; Wang J; Lu H
    Biosci Trends; 2021 Nov; 15(5):341-344. PubMed ID: 34456212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Strict State Measures on the Epidemiologic Curve of COVID-19 Infection in the Context of a Developing Country: A Simulation from Jordan.
    Kheirallah KA; Alsinglawi B; Alzoubi A; Saidan MN; Mubin O; Alorjani MS; Mzayek F
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32911738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of stringent non-pharmaceutical interventions applied during the second and third COVID-19 epidemic waves in Portugal, 9 November 2020 to 10 February 2021: an ecological study.
    Torres AR; Rodrigues AP; Sousa-Uva M; Kislaya I; Silva S; Antunes L; Dias C; Nunes B
    Euro Surveill; 2022 Jun; 27(23):. PubMed ID: 35686568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling how face masks and symptoms-based quarantine synergistically and cost-effectively reduce SARS-CoV-2 transmission in Bangladesh.
    Ferguson EA; Brum E; Chowdhury A; Chowdhury S; Kundegorski M; Mahmud AS; Purno N; Sania A; Steenson R; Tasneem M; Hampson K
    Epidemics; 2022 Sep; 40():100592. PubMed ID: 35738153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Wave of COVID-19 Pandemic in Italy: Data and Evidence.
    Bezzini D; Schiavetti I; Manacorda T; Franzone G; Battaglia MA
    Adv Exp Med Biol; 2021; 1353():91-113. PubMed ID: 35137370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in the Effectiveness of Non-pharmaceutical Interventions During the First SARS-CoV2 Wave in the United States.
    Pan WK; Fernández D; Tyrovolas S; Iago GV; Dasgupta RR; Zaitchik BF; Lantos PM; Woods CW
    Front Public Health; 2021; 9():754696. PubMed ID: 34912768
    [No Abstract]   [Full Text] [Related]  

  • 13. A modelling analysis of the effectiveness of second wave COVID-19 response strategies in Australia.
    Milne GJ; Xie S; Poklepovich D; O'Halloran D; Yap M; Whyatt D
    Sci Rep; 2021 Jun; 11(1):11958. PubMed ID: 34099788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks.
    Kohanovski I; Obolski U; Ram Y
    Int J Infect Dis; 2022 Apr; 117():361-368. PubMed ID: 34986406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.
    Shattock AJ; Le Rutte EA; Dünner RP; Sen S; Kelly SL; Chitnis N; Penny MA
    Epidemics; 2022 Mar; 38():100535. PubMed ID: 34923396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public Perceptions and Attitudes Toward COVID-19 Nonpharmaceutical Interventions Across Six Countries: A Topic Modeling Analysis of Twitter Data.
    Doogan C; Buntine W; Linger H; Brunt S
    J Med Internet Res; 2020 Sep; 22(9):e21419. PubMed ID: 32784190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
    Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
    BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.
    Pan J; Zhu W; Tian J; Liu Z; Xu A; Yao Y; Wang W
    Infect Dis Poverty; 2022 Mar; 11(1):36. PubMed ID: 35346382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.